Kaleido Biosciences, Inc.
KLDO · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$90,288 | -$81,620 | -$86,331 | -$61,744 |
| Dep. & Amort. | $2,358 | $1,823 | $1,318 | $792 |
| Deferred Tax | -$129 | $167 | $328 | $1,114 |
| Stock-Based Comp. | $10,342 | $12,684 | $10,068 | $0 |
| Change in WC | -$263 | $4,551 | -$1,216 | $6,496 |
| Other Non-Cash | $886 | $877 | $37 | $62 |
| Operating Cash Flow | -$77,094 | -$61,518 | -$75,796 | -$46,316 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,129 | -$4,024 | -$3,586 | -$3,002 |
| Net Acquisitions | $438 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$691 | -$4,024 | -$3,586 | -$3,002 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$68 | $7,409 | -$105 |
| Stock Issued | $69,925 | $37,756 | $67,761 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $112 | $2,711 | -$528 | $99,012 |
| Financing Cash Flow | $70,037 | $40,399 | $74,642 | $98,907 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,748 | -$25,143 | -$4,740 | $49,589 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48,383 | $73,526 | $78,266 | $28,677 |
| End Cash | $40,635 | $48,383 | $73,526 | $78,266 |
| Free Cash Flow | -$78,223 | -$65,542 | -$79,382 | -$49,318 |